Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Brian Spada Joins UMF|PerfectCLEAN as Regional Sales Manager – Healthcare Markets

Infection prevention expert bolsters UMF|PerfectCLEAN’s growing healthcare team Northbrook, Ill. – March 29, 2023 – Marking the latest expansion of its growing healthcare business, UMF|PerfectCLEAN welcomes Brian Spada as Regional Sales Manager – Healthcare Markets. Brian is an accomplished sales professional who is skilled in client services and results-oriented client management. Most recently with EvaClean, he brings years…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Brian Spada Joins UMF|PerfectCLEAN as Regional Sales Manager – Healthcare Markets

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Infection prevention expert bolsters UMF|PerfectCLEAN’s growing healthcare team

Northbrook, Ill. – March 29, 2023 – Marking the latest expansion of its growing healthcare business, UMF|PerfectCLEAN welcomes Brian Spada as Regional Sales Manager – Healthcare Markets. Brian is an accomplished sales professional who is skilled in client services and results-oriented client management. Most recently with EvaClean, he brings years of healthcare infection prevention expertise.

“We are thrilled to add Brian to our rapidly expanding healthcare team,” said Mark Hodgson, Vice President Sales – Healthcare Markets, UMF|PerfectCLEAN. “His deep knowledge of research-based, science-driven infection prevention solutions comes from years of partnering with some of the country’s leading healthcare facilities. He has helped such organizations achieve industry-leading safety scores and infection rates. Brian’s breadth of experience extends to education, and collegiate and professional sports. We look forward to working with Brian as we enter an exciting new phase of growth.”

Brian has proven abilities in sales and revenue growth, client based expansion, retention, and implementation. While at EvaClean, he co-developed the PurExcellance program, encompassing chemistry adaptation and a specialized clinical training program focused on reducing preventable healthcare associated infections (pHAIs) at healthcare facilities. He trained thousands of hospital staff members during his time there, and regularly exceeded performance goals. Prior to EvaClean, Brian was Regional Sales Manager at Interactive Metronome, where he brought their biometric technology platform to neurologists at leading hospitals and private practices in the Northeast and Caribbean. Before that, he spent more than nine years in sales at Steris, a division of SC Johnson’s DebMed, where he served major hospitals in the Northeast.

“I am thrilled to join UMF|PerfectCLEAN, which is on the cutting edge of infection prevention solutions, development, and innovation,” said Spada. “Committed to sustainability across the board, UMF|PerfectCLEAN is dedicated to ensuring safe environments for patients and healthcare professionals, alike. I am especially enthusiastic to join a company where caregivers and the customers they serve are the top priority.”

“We are thrilled to welcome Brian to our team,” said UMF|PerfectCLEAN CEO George Clarke. “Brian is already contributing to our mission of providing safe environments across all the markets we serve supported by best-in-class products, training, and solutions.”

About UMF Corporation

UMF Corporation is the leader in the research and development of high-performance products, programs and training for the infection prevention and commercial cleaning markets. Through extensive testing, exhaustive analysis and the commitment of significant human and financial resources, new antimicrobial technologies have been merged with innovative product designs that are redefining the future of clean®. LinkedIn.

Media Contact

Michelle Meek

(p) 773-220-3120

michelle@redpillchicago.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS's ACCESS payment model, fully active as of July 2026, pays companies $90 to $420 per Medicare beneficiary per year for technology-supported chronic care tied to outcomes, according to HFMA. The model also requires participants to connect through CMS-designated interoperability networks, and more tech companies than traditional providers have signed on so far.

  • 01CMS ACCESS model provides annual payments of $90 to $420 per Medicare beneficiary for chronic care supported by technology.
  • 02Payments in the ACCESS model range from $90 to $420 per beneficiary per year depending on whether specified outcome targets are met.
  • 03The initiative aims to promote the integration of technology in chronic care management.

Sep 10, 2026

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512